Genetic Signatures are proud to exhibit at the Australian Society for Microbiology Annual Scientific Meeting (ASM) 2017 in Hobart, Tasmania on 2-5 July 2017. Genetic Signatures has also been selected to present 4 oral papers at ASM 2017 Tasmania, in the following sessions: Monday 3rd July, 2017 10:30-12:00pm EST Session: Laboratory Processes and Automation “Clinical evaluation…

Genetic Signatures are pleased to be exhibiting at ASM Microbe 2017 in New Orleans, Louisiana, United States, 1-5 June 2017. The ASM Microbe conference showcases the best microbial sciences in the world and provides a one-of-a-kind forum to explore the complete spectrum of microbiology from basic science to translation and application. You are invited to…

Genetic Signatures will be exhibiting at the 33rd ASM Clinical Virology Symposium (CVS) Savannah, Georgia, United States, 07-10 May 2017. Presented by ASM- The Clinical Virology Symposium is a 3-day event highlighting the relationship between rapid viral diagnosis, clinical course of viral infections and preventive and therapeutic modalities for viral infections being the theme of…

Genetic Signatures’ Chief Scientific Officer, Dr Doug Millar, will be presenting at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) on the 23rd April 2017 in Vienna, Austria. Dr Millar will present results on the development of a 3base™ Flavivirus and Alphavirus Detection kit. The test allows for the detection of 15…

Molecular diagnostics (MDx) company Genetic Signatures’ Chief Scientific Officer, Dr Doug Millar has been selected to present at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), to be held 22-25 April 2017 in Vienna, Austria. The presentation will highlight Genetic Signatures’ proprietary 3base™ technology and upcoming EasyScreenTM detection kits, including the EasyScreen™…

Molecular diagnostics (MDx) company Genetic Signatures’ CEO Dr John Melki and CSO Dr Doug Miller will present at the inaugural Gene Target Solutions Symposium: qPCR, Past Present and Future on the 13-14th March 2017 in Sydney, Australia. CEO Dr Melki’s presentation is entitled “History of 3base™ technology and its application in molecular diagnostics.” The presentation will…

Molecular diagnostics (MDx) company Genetic Signatures Ltd will exhibit at the 24th International Molecular Medicine TRI-Conference (MMTC) in San Francisco, CA on 20th–22nd February 2017. Genetic Signatures will be exhibiting their novel products for the detection of infectious diseases, including reagents for diagnosing bacterial, viral and protozoan causes of gastroenteritis, respiratory infections and Sexually Transmitted Infections.…

Genetic Signatures will exhibit at the 16th Asia-Pacific Congress of Clinical Microbiology and Infection (APCCMI) in Melbourne, Australia on 30 November – 3 December 2016. Genetic Signatures will be exhibiting their EasyScreen products for the detection of infectious diseases, including kits for diagnosing bacterial, viral and protozoan causes of gastroenteritis direct from faeces, and the causes…

Genetic Signatures to present its global growth strategy for the development and supply of world leading molecular diagnostic products  The largest conference in Australia focused on microcap investment opportunities  Presentations from the CEOs of 24 of Australia’s leading emerging companies  Molecular Diagnostic (MDx) company Genetic Signatures (ASX: GSS) is pleased to release a copy of…

Genetic Signatures EasyScreen™ Pathogen Detection Kits will be featured in two oral presentations at the upcoming NRL Workshop on Molecular Diagnostics in Melbourne, Australia. The NRL Molecular Workshop is a forum for scientists, regulators, test kit manufacturers and clinicians to unite and discuss current issues and new technologies occurring in the world of molecular pathology…